Skip to main content
Health Podcast Library
Season 1 • Episode 77

Cancer Early Detection with Douglas Micalizzi, MD, & Lecia Sequist, MD

Oncology Overdrive · 40 min

Episode Description

In this episode, host Shikha Jain, MD, speaks with Douglas Micalizzi, MD, and Lecia Sequist, MD, about adopting novel technologies for early detection, public perception of prevention screening and more. • Welcome to another exciting episode of Oncology Overdrive :58 • About Micalizzi 1:12 • About Sequist 2:26 • The interview 4:06 • Sequist's background and how she got into the screening and prevention area of oncology 4:21 • Micalizzi on his chemistry background and how he got into this space 8:03 • About the evolution of early detection and MGH's Cancer Early Detection and Diagnostics Clinic 11:47 • Who is involved in this clinic and how do you handle a patient's panic over seeing cancer specialists? 14:30 • Discussion on the New York Times article Not Everything We Call Cancer Should Be Called Cancer and nomenclatures surrounding the various cancer stages and types 19:29 • Public perception of screening and the "push" from people outside of medicine 28:49 • If someone could only listen to the last two minutes of this episode, what would you want them to take away? 36:31 • How to contact Micalizzi and Sequist 37:51 • Thanks for listening 39:14

Douglas Micalizzi, MD, is a medical oncologist at Massachusetts General Hospital specializing in breast cancer, early cancer detection and hereditary cancer risk.

Lecia V. Sequist, MD, MPH, is currently the Landry Family Professor of Medicine at Harvard Medical School, the Program Director for Cancer Early Detection and Diagnostics at MGH and the leader of the Cancer Risk, Prevention and Early Detection Program at the joint Dana-Farber/Harvard Cancer Center.

We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X, formerly known as Twitter, and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X, formerly known as Twitter: @ShikhaJainMD. Micalizzi and Sequist can be reached through the Massachusetts General Hospital Cancer Early Detection and Diagnostics Clinic webpage. Sequist can also be reached on X, formerly known as Twitter @LeciaSequist. Disclosures: Jain and Micalizzi report no relevant financial disclosures. Sequist reports her institution has received funds related to clinical trials from AstraZeneca, Delfi Diagnostics and Novartis.

Proudly Supported by

BetterHelpForvis MazarsAAOSCalendarPAmowPod

Patrons of Health Podcast Library

AAOS Now Podcast
AAOS Career Podcast
Achieving Health
OrthoInfo
Who the Health Cares? with Prof Michael Sparer
Aging Like a Pro
Stronger After Stroke

Supporting Shows

Coffee Break: Breaking the Cycle of Bullying in Healthcare, One Cup at a Time
HIT Like a Girl Pod: Empowering Women in Health IT
Faces of Digital Health
Impulse | Meeting Healthcare Pioneers
Nurse Rosa's INsights
Beyond The Paper Gown Podcast
Hopeful Hints
Healthcare for Humans
Speak Up For Your Health
Coaching Healthcare Leaders
This Just In Radio Show
Thriving with Addiction with Dr. Jonathan Avery
Beyond Clinical Walls
HITea With Grace
Cuts and Consults
On the Pulse Podcast

We use cookies to run this site. Analytics cookies, which show us how it's used, stay off unless you accept them. Change your mind any time with the cookie button at the bottom right. How we use cookies